UMIN ID: UMIN000011105
Registered date:03/07/2013
Virological efficacy and safety of telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Chronic hepatitis C |
| Date of first enrollment | 2011/12/01 |
| Target sample size | 150 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Sustained virological response |
|---|---|
| Secondary Outcome | Predictors of SVR Adverse effects |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen Hepatic decompensation (Child B or C) Excessive active alcohol consumption |
Related Information
| Primary Sponsor | The Kyushu University Liver Disease Study (KULDS) Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Kyushu University Hospital |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Eiichi Ogawa |
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka Japan |
| Telephone | 092-642-5909 |
| eogawa@gim.med.kyushu-u.ac.jp | |
| Affiliation | The Kyushu University Liver Disease Study (KULDS) Group Department of General Internal Medicine, Kyushu University Hospital |
| scientific contact | |
| Name | Jun Hayashi |
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka Japan |
| Telephone | 092-642-5909 |
| hayashij@gim.med.kyushu-u.ac.jp | |
| Affiliation | The Kyushu University Liver Disease Study (KULDS) Group Kyushu University Hospital |